Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Accelerate Diagnosti (AXDX)

Accelerate Diagnosti (AXDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Accelerate Diagnosti 3950 South Country Club Road Suite 470 Tucson AZ 85714 USA

https://acceleratediagnostics.com P: 520-365-3100 F: 520-269-6580

Description:

Accelerate Diagnostics, Inc. is focused on developing and commercializing instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens. The company is developing BACcel(TM) system, a rapid diagnostic platform for diagnosis in life-threatening bacterial infections and OptiChem(R) surface coatings for use in micro arraying components. Accelerate Diagnostics Inc., formerly known as Accelr8 Technology Corp., is based in Denver, Colorado.

Key Statistics

Overview:

Market Capitalization, $K 14,423
Enterprise Value, $K -3,627
Shares Outstanding, K 14,569
Annual Sales, $ 12,750 K
Annual Net Income, $ -62,490 K
Last Quarter Sales, $ 3,300 K
Last Quarter Net Income, $ 910 K
EBIT, $ -57,450 K
EBITDA, $ -53,040 K
60-Month Beta 0.51
% of Insider Shareholders 33.00%
% of Institutional Shareholders 17.14%
Float, K 9,761
% Float 67.00%
Short Volume Ratio 0.64

Growth:

1-Year Return -80.42%
3-Year Return -98.89%
5-Year Return -99.47%
5-Year Revenue Growth 205.02%
5-Year Earnings Growth 34.48%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.92 on 11/09/23
Latest Earnings Date 03/28/24 [AMC]
Earnings Per Share ttm -6.38
EPS Growth vs. Prev Qtr 61.02%
EPS Growth vs. Prev Year 48.89%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-10 on 07/12/23

AXDX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -137.08%
Profit Margin % -490.12%
Debt/Equity 0.00
Price/Sales 0.95
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -2.44
Interest Coverage -15.60
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar